Citations

Clear

6 citation(s) found for "Schmidt, Kathryn".

Association Between Transjugular Intrahepatic Shunt (TIPS) and Waitlist Outcomes in Simultaneous Liver Kidney (SLK) Transplant Candidates
Schmidt, Kathryn A. , Meier, Tristan, Cole, Kristin, Olson, Jody C. , Taner, Timuçin , Riad, Samy , Mara, Kristin C. , Schmidt, Kathryn , Riad, Samy M. , Mara, Kristin C , Simonetto, Douglas A. , Meier, Tristan

Mayo Clinic

Clinical Transplantation | August 13, 2025 | Volume: 39 | Issue: 8 | Pages: No page available

10.1111/ctr.70279 | PMID 40802257 Get It

ABSTRACT Background The association between transjugular intrahepatic portosystemic shunt TIPS and waitlist outcomes in simultaneous liver‐kidney (SLK) transplant recipients remains unclear. Methods Between 2003 and 2023, we examined the scientific registry of transplant recipients. All adult candidates with overlapping waiting lists for liver and kidney transplants ( N = 15 087) were analyzed (entire cohort). Candidates without TIPS ( n = 13 980) and with ( n = 1107) were followed through November 30, 2023, and the following outcomes were analyzed: death, SLK transplant, liver‐ or kidney‐alone transplant, or removal from the list. The Aalen–Johansen method was used to calculate the cumulative incidence rates of the outcomes, where the outcomes were considered competing risks. Mixed effects Cox proportional hazard models were used to compare the outcomes by TIPS status. We separately analyzed dialysis‐dependent candidates ( n = 10 370). Results In the entire cohort, the 1‐year cumulative incidence of death in those without TIPS was higher than in those with (12.5% vs. 9%). In the dialysis‐dependent cohort, the 1‐year death incidence was 13.3% versus 8.8% in those without TIPS and those with, respectively. In the multivariable Cox proportional hazard models, TIPS was associated with a 29% lower mortality risk in the entire cohort (HR = 0.71, 95% CI: 0.60–0.84, p < 0.001) and a 33% lower risk of mortality in the dialysis‐dependent cohort. The likelihood of receiving SLK was lower for recipients with TIPS in the univariable analysis. However, this association was attenuated after adjustment. The causes of removal were similar irrespective of TIPS status in both cohorts. Conclusion In this large cohort of SLK candidates, those with TIPS had a better waitlist survival, irrespective of their dialysis requirements before transplantation. Prospective studies are needed to validate these findings.
Outcomes of Simultaneous Liver–Kidney Transplant Recipients According to Pre-Transplant Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the United States
Meier, Tristan, Schmidt, Kathryn, Mara, Kristin C. , Olson, Jody C. , Taner, Timuçin , Riad, Samy , Riad, Samy M. , Taner, Timucin , Mara, Kristin C , Meier, Tristan , Simonetto, Douglas A.

Mayo Clinic

Transplantology | October 17, 2024 | Volume: 5 | Issue: 4 | Pages: 234-245

10.3390/transplantology5040023 Get It

Background: Previous data suggested that the outcomes for liver-alone transplant recipients following transjugular intrahepatic portosystemic shunt (TIPS) insertion were comparable to those without TIPS. This study investigates the association between TIPS and outcomes among simultaneous liver–kidney (SLK) recipients in the United States. Methods: Utilizing the Scientific Registry for Transplant Recipients (SRTR) standard analysis file from 2003 to 2022, we examined 9717 adult SLK recipients, among whom 858 had undergone TIPS before transplantation. Kaplan–Meier curves were generated to assess recipient and death-censored liver and kidney graft survival. Mixed-effects Cox proportional hazard models were employed to analyze the association between TIPS and the outcomes of interest, where the transplant center was treated as a random effect. The models were adjusted for recipient age, sex, MELD score, diabetes, duration of listing, induction, steroid maintenance, hepatitis C status, donor age, donor sex, cold ischemia time, local vs. shipped organs, and allocation era. Results: Overall, the two groups were comparable, with minor differences. Notably, the median liver waiting time was significantly longer in the TIPS group compared to the non-TIPS group (4.1 vs. 2 months, p < 0.001). One-year rejection rates for liver and kidney allografts did not differ significantly between groups. Univariable Cox regression analyses demonstrated no association between TIPS and worse outcomes for recipient, liver, and kidney survival (p = 0.65, p = 0.22, and p = 0.54, respectively). TIPS did not emerge as a predictor of recipient or death-censored liver or kidney graft survival in multivariable models. Conclusion: In this extensive national cohort of SLK transplant recipients, pre-transplant TIPS was not linked to adverse outcomes for recipients or their allografts.
V-310.4: Outcomes of simultaneous liver kidney transplant recipients according to pre-transplant transjugular intrahepatic portosystemic shunt (TIPS) in the United States
Meier, Tristan, Schmidt, Kathryn, Cole, Kristin, Olson, Jody C. , Taner, Timucin, Meier, Tristan, Cole, Kristin, Simonetto, Douglas A. , Riad, Samy

Mayo Clinic

Transplantation | September 16, 2024 | Volume: 108 | Issue: 9S | Pages: No page available

10.1097/01.tp.0001066848.22361.76 Get It

Design, implementation, and impact of a cirrhosis-specific remote patient monitoring program
Penrice, Daniel D. , Hara, Kamalpreet S. , Chara, Beatriz Sordi , Kezer, Camille A. , Schmidt, Kathryn A. , Kassmeyer, Blake , Lennon, Ryan J. , Rosedahl, Jordan K., Roellinger, Daniel , Rattan, Puru , Williams, Katherine, Leuenberger, Angela , Kamath, Patrick S. , Shah, Vijay H. , Sordi Chara, Beatriz , Kezer, Camille , Schmidt, Kathryn, Lennon, Ryan, Rosedahl, Jordan, Kloft-Nelson, Sara, Kamath, Patrick S , Simonetto, Douglas A , Penrice, Daniel , Lennon, Ryan J. , Kloft‐Nelson, Sara M. , Simonetto, Douglas A.

Mayo Clinic

Hepatology Communications | July 22, 2024 | Volume: 8 | Issue: 8 | Pages: No page available

10.1097/hc9.0000000000000498 | PMID 39037370 Get It

Background: Remote patient monitoring (RPM) is an emerging focus in health care, and specialized programs may reduce medical costs, supplement in-office visits, and improve patient satisfaction. In this study, we describe the development, feasibility, and early outcomes of an RPM program for patients with decompensated cirrhosis. Methods: Forty-six patients were offered enrollment at the time of hospital discharge in the cirrhosis RPM program (CiRPM), of which 41 completed at least 30 days of monitoring. Participants were mailed remote monitoring equipment and a tablet to be used for patient-reported outcomes. Alerts were continuously monitored by virtual nursing staff who could perform targeted interventions. A cohort of historical controls (n = 74) was created for comparison using inverse probability of treatment weighting. Results: Patients were enrolled in the program for a mean of 83.9 days, with 28 (68%) completing the full 90-day program. Participants uploaded vital signs and responded to symptom-based questionnaires on 93% of the monitored days. On end-of-program surveys, over 75% of patients expressed satisfaction with the program. Gender, age, and MELD-Na were similar between CiRPM and weighted control groups. The 90-day readmission rate was 34% in CiRPM and 47% in weighted controls. In the CiRPM group, 12% of subjects had 2 or more admissions, compared to 37% in the weighted control group. Conclusion: This study demonstrates the feasibility of a cirrhosis-specific RPM program. Overall, patient satisfaction and utilization of the CiRPM was high. Future studies are needed to confirm the impact of RPM on the reduction of hospital readmissions in decompensated cirrhosis.
Artificial Intelligence–Enabled Stool Analysis for Lactulose Titration Assistance in Hepatic Encephalopathy Through a Smartphone Application
Chara, Beatriz Sordi , Hara, Kamalpreet S. , Schmidt, Kathryn A. , Kassmeyer, Blake A., Anstey, Jacob, Tiede, David, Kamath, Patrick S. , Shah, Vijay H. , Bajaj, Jasmohan S. , Kraus, Asaf, Sordi Chara, Beatriz , Penrice, Daniel , Kamath, Patrick S , Bajaj, Jasmohan S , Penrice, Daniel D. , Simonetto, Douglas A.

Mayo Clinic

American Journal of Gastroenterology | January 19, 2024 | Volume: 119 | Issue: 5 | Pages: 982-986

10.14309/ajg.0000000000002656 | PMID 38240303 Get It

INTRODUCTION: Management of hepatic encephalopathy relies on self-titration of lactulose. In this feasibility trial, we assess an artificial intelligence–enabled tool to guide lactulose use through a smartphone application. METHODS: Subjects with hepatic encephalopathy on lactulose captured bowel movement pictures during lead-in and intervention phases. During the intervention phase, daily feedback on lactulose titration was delivered through the application. Goals were determined according to number of bowel movement and Bristol Stool Scale reports. RESULTS: Subjects completed the study with more than 80% satisfaction. In the lead-in phase, less compliant subjects achieved Bristol Stool Scale goal on 62/111 (56%) of days compared with 107/136 (79%) in the intervention phase ( P = 0.041), while the most compliant subjects showed no difference. Severe/recurrent hepatic encephalopathy group achieved Bristol Stool Scale goal on 80/104 (77%) days in the lead-in phase and 90/110 (82%) days in the intervention phase ( P = NS), compared with 89/143 (62%) days and 86/127 (68%) days in the stable group. DISCUSSION: Dieta application is a promising tool for objective Bowel Movement/Bristol Stool Scale tracking for hepatic encephalopathy and may potentially be used to assist with lactulose titration.
Minimizing Metabolic and Cardiac Risk Factors to Maximize Outcomes After Liver Transplantation
Schmidt, Kathryn, Khan, Mohammad Qasim, Izzy, Manhal , Watt, Kymberly D. , Khan, Mohammad Qasim , Spann, Ashley , Khan, Mohammad Qasim, Khan, Mohammad Qasim

Mayo Clinic

Transplantation | December 7, 2023 | Volume: 108 | Issue: 8 | Pages: 1689-1699

10.1097/tp.0000000000004875 | PMID 38060378 Get It

Cardiovascular disease (CVD) is a leading complication after liver transplantation and has a significant impact on patients’ outcomes posttransplant. The major risk factors for post–liver transplant CVD are age, preexisting CVD, nonalcoholic fatty liver disease, chronic kidney disease, and metabolic syndrome. This review explores the contemporary strategies and approaches to minimizing cardiometabolic disease burden in liver transplant recipients. We highlight areas for potential intervention to reduce the mortality of patients with metabolic syndrome and CVD after liver transplantation.